Boston Scientific Corporation - Income Statement (TTM)

Boston Scientific Corporation
AT ˙ WBAG ˙ FR0010424135
€ 88,40 ↑0.60 (0.68%)
2025-07-10
SHARE PRICE
Income Statement (TTM)

Boston Scientific Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 10,108 9,913 10,122 11,196 11,470 11,888 12,162 12,329 12,567 12,682 13,045 13,400 13,757 14,240 14,707 15,229 15,911 16,747 17,554 18,494
Change (%) -1.93 2.11 10.61 2.45 3.64 2.30 1.37 1.93 0.92 2.86 2.72 2.66 3.51 3.28 3.55 4.48 5.25 4.82 5.35
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 3,287 3,242 3,208 3,367 3,400 3,760 3,821 3,886 3,962 4,003 4,087 4,135 4,257 4,391 4,559 4,768 4,973 5,290 5,538 5,910
Change (%) -1.37 -1.05 4.96 0.98 10.59 1.62 1.70 1.96 1.03 2.10 1.17 2.95 3.15 3.83 4.58 4.30 6.37 4.69 6.72
% of Revenue 32.52 32.70 31.69 30.07 29.64 31.63 31.42 31.52 31.53 31.56 31.33 30.86 30.94 30.84 31.00 31.31 31.26 31.59 31.55 31.96
Gross Operating Profit 6,821 6,671 6,914 7,829 8,070 8,128 8,341 8,443 8,605 8,679 8,958 9,265 9,500 9,849 10,148 10,461 10,938 11,457 12,016 12,584
Change (%) -2.20 3.64 13.23 3.08 0.72 2.62 1.22 1.92 0.86 3.21 3.43 2.54 3.67 3.04 3.08 4.56 4.74 4.88 4.73
% of Revenue 67.48 67.30 68.31 69.93 70.36 68.37 68.58 68.48 68.47 68.44 68.67 69.14 69.06 69.16 69.00 68.69 68.74 68.41 68.45 68.04
SG&A 3,864 3,787 3,777 4,099 4,182 4,359 4,400 4,445 4,510 4,520 4,675 4,865 4,974 5,190 5,339 5,430 5,751 5,984 6,217 6,486
Change (%) -1.99 -0.26 8.53 2.02 4.23 0.94 1.02 1.46 0.22 3.43 4.06 2.24 4.34 2.87 1.70 5.91 4.05 3.89 4.33
% of Revenue 38.23 38.20 37.31 36.61 36.46 36.67 36.18 36.05 35.89 35.64 35.84 36.31 36.16 36.45 36.30 35.66 36.14 35.73 35.42 35.07
R&D 1,165 1,143 1,115 1,171 1,166 1,204 1,247 1,284 1,313 1,323 1,341 1,364 1,381 1,414 1,443 1,468 1,519 1,615 1,692 1,835
Change (%) -1.89 -2.45 5.02 -0.43 3.26 3.57 2.97 2.26 0.76 1.36 1.72 1.25 2.39 2.05 1.73 3.47 6.32 4.77 8.45
% of Revenue 11.53 11.53 11.02 10.46 10.17 10.13 10.25 10.41 10.45 10.43 10.28 10.18 10.04 9.93 9.81 9.64 9.55 9.64 9.64 9.92
OpEx 9,112 8,961 8,873 9,393 9,491 10,064 10,222 10,393 10,581 10,649 10,911 11,177 11,431 11,823 12,180 12,509 13,082 13,745 14,308 15,104
Change (%) -1.66 -0.98 5.86 1.04 6.04 1.57 1.67 1.81 0.64 2.46 2.44 2.27 3.43 3.02 2.70 4.58 5.07 4.10 5.56
% of Revenue 90.15 90.40 87.66 83.90 82.75 84.66 84.05 84.30 84.20 83.97 83.64 83.41 83.09 83.03 82.82 82.14 82.22 82.07 81.51 81.67
Operating Income 996 952 1,249 1,803 1,979 1,824 1,940 1,936 1,986 2,033 2,134 2,223 2,326 2,417 2,527 2,720 2,829 3,002 3,246 3,390
Change (%) -4.42 31.20 44.36 9.76 -7.83 6.36 -0.21 2.58 2.37 4.97 4.17 4.63 3.91 4.55 7.64 4.01 6.12 8.13 4.44
% of Revenue 9.85 9.60 12.34 16.10 17.25 15.34 15.95 15.70 15.80 16.03 16.36 16.59 16.91 16.97 17.18 17.86 17.78 17.93 18.49 18.33
Interest Expense -444 -361 -355 -350 -350 -341 -538 -516 -493 -470 -256 -262 -264 -265 -269 -276 -290 -305 -318 -331
Change (%) -18.69 -1.66 -1.41 -0.00 -2.57 57.77 -4.09 -4.46 -4.67 -45.53 2.34 0.76 0.38 1.51 2.60 5.07 5.17 4.26 4.09
% of Revenue -4.39 -3.64 -3.51 -3.13 -3.05 -2.87 -4.42 -4.19 -3.92 -3.71 -1.96 -1.96 -1.92 -1.86 -1.83 -1.81 -1.82 -1.82 -1.81 -1.79
Net Income 3,704 -82 248 582 1,156 1,041 810 884 653 698 902 912 1,228 1,593 1,774 1,828 1,792 1,854 2,033 2,506
Change (%) -102.21 -402.44 134.68 98.63 -9.95 -22.19 9.14 -26.13 6.89 29.23 1.11 34.65 29.72 11.36 3.04 -1.97 3.46 9.65 23.27
% of Revenue 36.64 -0.83 2.45 5.20 10.08 8.76 6.66 7.17 5.20 5.50 6.91 6.81 8.93 11.19 12.06 12.00 11.26 11.07 11.58 13.55

Source: Capital IQ

Other Listings
IT:1BSX € 92,80
MX:BSX
DE:BSX € 91,20
US:BSX US$ 107,22
GB:0HOY US$ 107,30
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista